Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice

Infection and Immunity

Volumn 65, Issue 8, 1997, Pages 3118-3125

  Ryan, Edward T ^a   Butterton, Joan R ^a   Zhang, Tonghai ^b   Baker, Meghan A ^a   Stanley Jr , Samuel L ^b   Calderwood, Stephen B ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; PROTOZOAL PROTEIN;

AMEBIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIPROTOZOAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHOLERA; CONTROLLED STUDY; DNA SEQUENCE; ENTAMOEBA HISTOLYTICA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GERMFREE ANIMAL; IMMUNIZATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIBRIO CHOLERAE;

EID: 0030837709     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.8.3118-3125.1997     Document Type: Article

References (43)

1. Acheson, D. W. K., M. M. Levine, J. B. Kaper, and G. T. Keusch. 1996. Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-suhunit-producing Vibrio cholerae CVD 103-HgR. Infect. Immun. 64:355-357.
2. Backstrom, M., M. Lebens, F. Schodel, and J. Holmgren. 1994. Insertion of a HIV-1 neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit. Gene 149:211-217.
3. Bergquist, C., T. Lagergard, M. Lindblad, and J. Holmgren. 1995. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect. Immun. 63:2021-2025.
4. Brown, W. R., and T. M. Kloppel. 1989. The liver and IgA: immunological, cell biological and clinical implications. Hepatology 9:763-784.
5. Butterton, J. R., D. T. Beattie, C. L. Gardel, P. A. Carroll, T. Hyman, K. P. Killeen, J. J. Mekalanos, and S. B. Calderwood. 1995. Heterologous antigen expression in Vibrio cholerae vector strains. Infect. Immun. 63:2689-2696.
6. Butterton, J. R., S. A. Boyko, and S. B. Calderwood. 1993. Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains. Vaccine 11:1327-1335.
7. Butterton, J. R., E. T. Ryan, D. W. K. Acheson, and S. B. Calderwood. 1997. Compression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect. Immun. 65:2127-2135.
8. Butterton, J. R., E. T. Ryan, R. A. Shahin, and S. B. Calderwood. 1996. Development of a germfree mouse model of Vibrio cholerae infection. Infect. Immun. 64:4373-4377.
9. Carrero, J. C., M. Yadira Diaz, M. Viveros, B. Espinoza, E. Acosta, and L. Ortiz-Ortiz. 1994. Human secretory immunoglobulin A anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells. Infect. Immun. 62:764-767.
10. Cieslak, P. R., T. Zhang, and S. L. Stanley. Jr. 1993. Expression of a recombinant Entamoeba histolytica antigen in a Salmonella typhimurium vaccine strain. Vaccine 11:773-776.
11. Dertzbaugh, M. T., and C. O. Elson. 1993. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect. Immun. 61:48-55.
12. Goldberg, M. B., S. A. Boyko, and S. B. Calderwood. 1991. Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 88:1125-1129.
13. Holmgren, J., C. Czerkinsky, N. Lycke, and A. M. Svennerholm. 1994. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier and adjuvant. Am. J. Trop. Mod. Hyg. 50(Suppl.):42-54.
14. Hovde, C. J., S. B. Calderwood, J. J. Mekalanos, and R. J. Collier. 1988. Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc. Natl. Acad. Sci. USA 85:2568-2572.
15. Jarumilinta, R., and F. Kradolfer. 1964. The toxic effect of Entamoeba histolytica on leucocytes. Ann. Trop. Med. Parasitol. 58:375-381.
16. Kaper, J. B., J. Michalski, J. M. Ketley, and M. M. Levine. 1994. Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD103-HgR. Infect. Immun. 62:1480-1483.
17. Levine, M. M., R. E. Black, M. L. Clements, L. Cisneros, D. R. Nalin, and C. R. Young. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820.
18. Levine, M. M., J. B. Kaper, D. Herrington, J. Ketley, G. Losonsky, C. O. Tacket, B. Tall, and S. Cryz. 1988. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD103 and CVD103-HgR. Lancet ii:467-470.
19. Li, E., A. Becker, and S. L. Stanley, Jr. 1989. Chinese hamster ovary cells deficient in N-acetylglycosaminyltransferase I activity are resistant to Entamoebic histolytica-mediated cytotoxicity. Infect. Immun. 57:8-12.
20. Mekalanos, J. J., D. J. Swartz, G. D. Pearson, N. Harford, F. Groyne, and M. de Wilde. 1983. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature 306:551-557.
21. Owen, R. L., N. F. Pierce, R. T. Apple, and W. C. Gray, Jr. 1986. M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbiological transepithelial migration. J. Infect. Dis. 153:1108-3118.
22. Pearson, G. D., A. Woods, S. L. Chiang, and J. J. Mekalanos. 1993. CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc. Natl. Acad. Sci. USA 90:3750-3754.
23. Quiding, M., I. Nordstrom, A. Kilander, G. Andersson, L. A. Hanson, J. Holmgren, and C. Czerkinsky. 1991. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J. Clin. Invest. 88:143-148.
24. Ravdin, J. I. 1995. Amebiasis. Clin. Infect. Dis. 20:1453-1466.
25. Ravdin, J. I., J. E. John, L. I. Johnston, D. J. Innes, and R. L. Guerrant. 1985. Adherence of Entamoeba histolytica trophozoites to rat and human colonic mucosa. Infect. Immun. 48:292-297.
26. Roberts, A., G. D. Pearson, and J. J. Mekalanos. 1992. Cholera vaccine strains derived from a Peruvian isolate of Vibrio cholerae and other El Tor strains. Presented at the 28th Joint Conference, U.S. - Japan Cooperative Medical Science Program on Cholera and Related Diarrheal Diseases.
27. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
28. Sanchez, J., A.-M. Svennerholm, and J. Holmgren. 1988. Genetic fusion of a non-toxic heat stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit. FEBS Lett. 241:110-114.
29. Seydel, K. B., K. L. Braun, T. Zhang, T. F. H. G. Jackson, and S. L. Stanley, Jr. 1996. Protection against amebic liver abscess formation in the severe combined immunodeficient mouse by human anti-amebic antibodies. Am. J. Trop. Med. Hyg. 55:330-332.
30. Soong, C. J., K. C. Kain, M. Abd-Alla, T. F. H. G. Jackson, and J. I. Ravdin. 1995. A recombinant-cysteine rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J. Infect. Dis 171:645-651.
31. Soong, C. J., M. D. Torian, M. D. Abd-Alla, T. F. H. G. Jackson, V. Gatharim, and J. I. Ravdin. 1995. Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen. Infect. Immun. 63:472-477.
32. Stanley, S. L., Jr. 1996. Progress towards an amebiasis vaccine. Parasitol. Today 12:7-13.
33. Stanley, S. L., Jr., A. Becker, C. Kunz-Jenkins, L. Foster, and E. Li. 1990. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats. Proc. Natl. Acad. Sci. USA 87:4976-4980.
34. Stanley, S. L., Jr., K. Tian, J. P. Koester, and E. Li. 1995. Entamoeba histolytica protein (SREHP) is a phosphorylated membrane protein containing O-linked terminal N-acetylglucosamine (O-GlcNAc) residues. J. Biol. Chem. 270:4121-4126.
35. Tacket, C. O., G. Losonsky, J. P. Nataro, L. Comstock, J. Michalski, R. Edelman, J. B. Kaper, and M. M. Levine. 1995. Initial clinical studies of CVD112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172:883-886.
36. Tautz, D., and M. Renz. 1983. An optimized freeze-squeeze method for the recovery of DNA fragments. Anal. Biochem. 132:14-19.
37. Taylor, D. N., K. P. Killeen, D. C. Hack, J. R. Kenner, T. S. Coster, D. T. Beattie, J. Ezzell, T. Hyman, A. Trofa, M. H. Sjogren, A. Friedlander, J. J. Mekalanos, and J. C. Sadoff. 1994. Development of a live, oral attenuated vaccine against El Tor cholera. J. Infect. Dis. 170:1518-1523.
38. Waldor, M. K., and J. J. Mekalanos. 1994. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype, J. Infect. Dis. 170:278-283.
39. Zhang, T., P. R. Cieslak, L. Foster, C. Kunz-Jenkins, and S. L. Stanley, Jr. 1994. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol. 16:225-230.
40. Zhang, T., P. R. Cieslak, and S. L. Stanley, Jr. 1994. Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen. Infect. Immun. 62:1166-1170.
41. Zhang, T., E. Li, and S. L. Stanley, Jr. 1995. Oral immunization with the dodecapeptide repeat of the serine-rich Entamaeba histolytica protein (SREHP) fused to cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Infect. Immun. 63:1349-1355.
42. Zhang, T., and S. L. Stanley, Jr. 1994. Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica. Infect. Immun. 62:2605-2608.
43. Zhang, T., and S. L. Stanley, Jr. 1996. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess. Infect. Immun. 64:1526-1531.